Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
#:"(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)"
topic_facet:"Medical Condition: Acute respiratory distress syndrome caused by Covid-19 MedDRA version: 21.1Level: PTClassification code 10001052Term: Acute respiratory distress syndromeSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]"
(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=%23%3A%22%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Acute+respiratory+distress+syndrome+caused+by+Covid-19+MedDRA+version%3A+21.1Level%3A+PTClassification+code+10001052Term%3A+Acute+respiratory+distress+syndromeSystem+Organ+Class%3A+10038738+-+Respiratory%2C+thoracic+and+mediastinal+disorders%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Respiratory+Tract+Diseases+%5BC08%5D%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject
/vufind/Search/Results?filter%5B%5D=%23%3A%22%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Acute+respiratory+distress+syndrome+caused+by+Covid-19+MedDRA+version%3A+21.1Level%3A+PTClassification+code+10001052Term%3A+Acute+respiratory+distress+syndromeSystem+Organ+Class%3A+10038738+-+Respiratory%2C+thoracic+and+mediastinal+disorders%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Respiratory+Tract+Diseases+%5BC08%5D%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=%23%3A%22%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Acute+respiratory+distress+syndrome+caused+by+Covid-19+MedDRA+version%3A+21.1Level%3A+PTClassification+code+10001052Term%3A+Acute+respiratory+distress+syndromeSystem+Organ+Class%3A+10038738+-+Respiratory%2C+thoracic+and+mediastinal+disorders%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Respiratory+Tract+Diseases+%5BC08%5D%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject
PubPharm (14)
1
The TRISTARDS trial - ThRombolysIS Therapy for ARDS A study to test whether different doses of alteplase help people with severe breathing problems because of COVID 19. : The TRISTARDS trial - ThRombolysIS Therapy for ARDSA Phase IIb/III operationally seamless, open-label, randomised, sequential, parallel-group adaptive study to evaluate the efficacy and safety of daily intravenous alteplase treatment given up to 5 days on top of standard of care (SOC) compared with SOC alone, in patients with acute respiratory distress syndrome (ARDS) triggered by COVID-19.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
2
The TRISTARDS trial - ThRombolysIS Therapy for ARDS A study to test whether different doses of alteplase help people with severe breathing problems because of COVID 19. : The TRISTARDS trial - ThRombolysIS Therapy for ARDSA Phase IIb/III operationally seamless, open-label, randomised, sequential, parallel-group adaptive study to evaluate the efficacy and safety of daily intravenous alteplase treatment given up to 5 days on top of standard of care (SOC) compared with SOC alone, in patients with acute respiratory distress syndrome (ARDS) triggered by COVID-19.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
3
The TRISTARDS trial - ThRombolysIS Therapy for ARDS A study to test whether different doses of alteplase help people with severe breathing problems because of COVID 19. : The TRISTARDS trial - ThRombolysIS Therapy for ARDSA Phase IIb/III operationally seamless, open-label, randomised, sequential, parallel-group adaptive study to evaluate the efficacy and safety of daily intravenous alteplase treatment given up to 5 days on top of standard of care (SOC) compared with SOC alone, in patients with acute respiratory distress syndrome (ARDS) triggered by COVID-19. - TRISTARDS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
4
The TRISTARDS trial - ThRombolysIS Therapy for ARDS A study to test whether different doses of alteplase help people with severe breathing problems because of COVID 19. : The TRISTARDS trial - ThRombolysIS Therapy for ARDSA Phase IIb/III operationally seamless, open-label, randomised, sequential, parallel-group adaptive study to evaluate the efficacy and safety of daily intravenous alteplase treatment given up to 5 days on top of standard of care (SOC) compared with SOC alone, in patients with acute respiratory distress syndrome (ARDS) triggered by COVID-19.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
5
The TRISTARDS trial - ThRombolysIS Therapy for ARDS A study to test whether different doses of alteplase help people with severe breathing problems because of COVID 19. : The TRISTARDS trial - ThRombolysIS Therapy for ARDSA Phase IIb/III operationally seamless, open-label, randomised, sequential, parallel-group adaptive study to evaluate the efficacy and safety of daily intravenous alteplase treatment given up to 5 days on top of standard of care (SOC) compared with SOC alone, in patients with acute respiratory distress syndrome (ARDS) triggered by COVID-19. - TRISTARDS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
6
The TRISTARDS trial - ThRombolysIS Therapy for ARDS A study to test whether different doses of alteplase help people with severe breathing problems because of COVID 19. : The TRISTARDS trial - ThRombolysIS Therapy for ARDSA Phase IIb/III operationally seamless, open-label, randomised, sequential, parallel-group adaptive study to evaluate the efficacy and safety of daily intravenous alteplase treatment given up to 5 days on top of standard of care (SOC) compared with SOC alone, in patients with acute respiratory distress syndrome (ARDS) triggered by COVID-19.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
7
The TRISTARDS trial - ThRombolysIS Therapy for ARDS A study to test whether different doses of alteplase help people with severe breathing problems because of COVID 19. : The TRISTARDS trial - ThRombolysIS Therapy for ARDSA Phase IIb/III operationally seamless, open-label, randomised, sequential, parallel-group adaptive study to evaluate the efficacy and safety of daily intravenous alteplase treatment given up to 5 days on top of standard of care (SOC) compared with SOC alone, in patients with acute respiratory distress syndrome (ARDS) triggered by COVID-19.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
8
The TRISTARDS trial - ThRombolysIS Therapy for ARDS A study to test whether different doses of alteplase help people with severe breathing problems because of COVID 19. : The TRISTARDS trial - ThRombolysIS Therapy for ARDSA Phase IIb/III operationally seamless, open-label, randomised, sequential, parallel-group adaptive study to evaluate the efficacy and safety of daily intravenous alteplase treatment given up to 5 days on top of standard of care (SOC) compared with SOC alone, in patients with acute respiratory distress syndrome (ARDS) triggered by COVID-19.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
9
The TRISTARDS trial - ThRombolysIS Therapy for ARDS A study to testwhether different doses of alteplase help people with severe breathingproblems because of COVID 19. : The TRISTARDS trial - ThRombolysIS Therapy for ARDSA Phase IIb/III operationally seamless, open-label, randomised,sequential, parallel-group adaptive study to evaluate the efficacy andsafety of daily intravenous alteplase treatment given up to 5 days on top ofstandard of care (SOC) compared with SOC alone, in patients with acuterespiratory distress syndrome (ARDS) triggered by COVID-19. - -
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
10
The TRISTARDS trial - ThRombolysIS Therapy for ARDS A study to testwhether different doses of alteplase help people with severe breathingproblems because of COVID 19. : The TRISTARDS trial - ThRombolysIS Therapy for ARDSA Phase IIb/III operationally seamless, open-label, randomised,sequential, parallel-group adaptive study to evaluate the efficacy andsafety of daily intravenous alteplase treatment given up to 5 days on top ofstandard of care (SOC) compared with SOC alone, in patients with acuterespiratory distress syndrome (ARDS) triggered by COVID-19. - -
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Filter aufheben
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Medical Condition: Acute respiratory distress syndrome caused by Covid-19 MedDRA version: 21.1Level: PTClassification code 10001052Term: Acute respiratory distress syndromeSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
Medienart
14
Aufsätze
14
E-Artikel
14
E-Ressourcen
Zeitschriftentitel
14
WHO International Clinical Trials Registry Plat...
Thema
14
610
Medical Condition: Acute respiratory distress s...
14
Phase: Phase 2
14
Recruitment Status: Authorised-recruitment may ...
14
Study Type: Interventional
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
8
2022
6
2021
Erscheinungsjahr(e)
Von:
Bis:
Sprache
14
Englisch
Haven't found what you're looking for?
Wird geladen...